MedCity News April 19, 2023
Medical robotics startup Noah Medical recently closed a $150 million Series B funding round. The company’s robotic platform, called the Galaxy System, was designed to help physicians find, biopsy and diagnose lung cancer lesions with more ease and confidence.
Lung cancer is the leading cause of cancer death in the U.S. A company seeking to address the healthcare system’s shortcomings in diagnosing the disease just reeled in $150 million.
On Wednesday, San Carlos, California-based medical robotics startup Noah Medical closed its Series B funding round. Investors included Softbank Vision Fund, Prosperity7 Ventures, Tiger Global, Hillhouse, Sequoia China, Shangbay Capital and Uphonest Capital. The company declined to disclose its total funding amount to date.
Noah was founded in 2018 to provide...
Today's Sponsors
Today's Sponsor